Meta's strong earnings report sent its stock soaring after hours. The company also made it clear that the AI talent wars come ...

Onvansertib combined with standard care showed up to 49% confirmed ORR in RAS-mutated colorectal cancer, with early signs of ...

Data analytics firm Verisk said on Wednesday it will buy AccuLynx, which makes software for roofing contractors, for $2.35 ...

Analysts say the departure of the CBER head may alleviate overhang in the cell and gene therapy space. Vinay Prasad, head of the Center for Biologics Evaluation and Research (CBER) at the US Food and ...

The abrupt exit of the former CBER director, who quickly made his mark at the agency with several high-profile and ...

But while many analysts presented a bullish case for the company's turnaround, not all investors are sold on Niccol and his ...